Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Rath

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Expert Opinion on Pharmacotherapy|December 12, 2012
Tacrolimus in transplant rejectionThomas Rath
MMW Fortschritte Der Medizin|August 23, 2013
[Minimally invasive surgery for the treatment of lung cancer--indications]Thomas Rath
MMW Fortschritte Der Medizin|April 18, 2018
[Pneumothorax]Thomas Rath, Andreas Imdahl
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 9, 2011
[Analysis and evaluation of the QUALIFY tool for assessing quality indicators with structured group interviews]Markus Lüngen, Thomas Rath
Plos One|October 12, 2013
Future bloom and blossom frost risk for Malus domestica considering climate model and impact model uncertaintiesHolger Hoffmann, Thomas Rath
American Journal of Nephrology|October 10, 2009
Mutagenicity of immunosuppressive medications among renal transplant recipientsThomas Rath, Vilma Oliveira-Frick
Journal of Transplantation|June 3, 2014
Anemia control in kidney transplant recipients using once-monthly continuous erythropoietin receptor activator: a prospective, observational studyKlemens Budde, Thomas Rath, Volker Kliem
Klinische Monatsblatter Fur Augenheilkunde|May 9, 2018
[Conventional Synthetic Disease-modifying Antirheumatic Drugs (DMARDs) for the Treatment of Non-infectious Uveitis]Christoph Tappeiner, Thomas Rath, Arnd Heiligenhaus
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte culturesVilma Duarte Oliveira, Heinrich Zankl, Thomas Rath
Klinische Monatsblatter Fur Augenheilkunde|April 15, 2022
Janus Kinase Inhibitors: Next-Generation Treatment for UveitisYosuf El-Shabrawi, Thomas Rath, Arnd Heiligenhaus
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Expert Opinion on Pharmacotherapy|December 12, 2012
Tacrolimus in transplant rejectionThomas Rath
MMW Fortschritte Der Medizin|August 23, 2013
[Minimally invasive surgery for the treatment of lung cancer--indications]Thomas Rath
MMW Fortschritte Der Medizin|April 18, 2018
[Pneumothorax]Thomas Rath, Andreas Imdahl
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 9, 2011
[Analysis and evaluation of the QUALIFY tool for assessing quality indicators with structured group interviews]Markus Lüngen, Thomas Rath
Plos One|October 12, 2013
Future bloom and blossom frost risk for Malus domestica considering climate model and impact model uncertaintiesHolger Hoffmann, Thomas Rath
American Journal of Nephrology|October 10, 2009
Mutagenicity of immunosuppressive medications among renal transplant recipientsThomas Rath, Vilma Oliveira-Frick
Journal of Transplantation|June 3, 2014
Anemia control in kidney transplant recipients using once-monthly continuous erythropoietin receptor activator: a prospective, observational studyKlemens Budde, Thomas Rath, Volker Kliem
Klinische Monatsblatter Fur Augenheilkunde|May 9, 2018
[Conventional Synthetic Disease-modifying Antirheumatic Drugs (DMARDs) for the Treatment of Non-infectious Uveitis]Christoph Tappeiner, Thomas Rath, Arnd Heiligenhaus
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte culturesVilma Duarte Oliveira, Heinrich Zankl, Thomas Rath
Klinische Monatsblatter Fur Augenheilkunde|April 15, 2022
Janus Kinase Inhibitors: Next-Generation Treatment for UveitisYosuf El-Shabrawi, Thomas Rath, Arnd Heiligenhaus
Pageof 11